MedPath

High dose folic acid supplementation effect on preeclampsia

Phase 4
Conditions
Preeclampsia.
Gestational [pregnancy-induced] hypertension with significant proteinuria
Registration Number
IRCT201507313944N4
Lead Sponsor
Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
900
Inclusion Criteria

all of women with living fetus in the uterine cavity in first trimester with willingness for participation in this study, were included and do not: Presence or history of a disorder in which administration of folic acid is contraindicated, renal diseases, using anti-epileptic drugs (since the metabolism of anti-epileptic drugs requires a great deal of folic acid), malignancy, alcohol abuse, multiple birth (presence of three living fetus or more) and known hypersensitivity to folic acid (rashes, dermatologic and gastroenterological discomforts).

Exclusion criteria: Fetal death during the study, major abnormality of the fetus, women who were planning to move outside of the catchment area of the study within the pregnancy duration.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Preeclampsia. Timepoint: first visit and routin prenatal care. Method of measurement: measurement blod pressure (mmHg) and proteinuria(mg/dl).
Secondary Outcome Measures
NameTimeMethod
Incidence of preeclampsia. Timepoint: during pregnancy. Method of measurement: using diagnostic criteria.;Severity of preeclampsia. Timepoint: during pregnancy. Method of measurement: using diagnostic criteria.;Prevalence of preeclampsia. Timepoint: during pregnancy. Method of measurement: using diagnostic criteria.
© Copyright 2025. All Rights Reserved by MedPath